Citigroup Global Markets India Pvt. Ltd. (Manager to the Offer) has submitted to the Exchange a copy of addendum to the Letter of Offer and Pre-Offer Advertisement and Corrigendum to the Detailed Public Statement and the Letter of Offer for the attention of the shareholders of Sanofi Consumer Healthcare India Ltd ( Target Company ).
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Citigroup Global Markets India, acting as Manager to the Offer, has submitted an addendum to the Letter of Offer and Pre-Offer Advertisement for the open offer to acquire up to 59,87,962 equity shares (26% of voting share capital) of Sanofi Consumer Healthcare India from public shareholders. The acquirer is Opal Bidco SAS, acting together with Clayton, Dubilier & Rice Fund XII, L.P. as a person acting in concert. The underlying transaction was completed on April 30, 2025, and the acquirer deposited additional cash on April 29, 2025 to bring the escrow to 100% of the maximum consideration. The addendum was published in Financial Express, Jansatta, and Navshakti on May 1, 2025.
Shareholders should review the addendum carefully as it may contain updated terms or corrections to the offer. With the underlying transaction now completed, the open offer is firmly in motion and public shareholders will need to decide whether to tender their shares at the offer price.